Clinical experience of successful treatment for radiation-induced breast angiosarcomas


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Radiation-induced breast angiosarcomas are an extremely rare disease characterized by a low response to available treatment options and by an unfavorable prognosis. The diagnosis is complex and requires histological and immunohistochemical verification. Description. This paper describes three clinical cases of patients treated for radiation-induced angiosarcomas in the N.N. Blokhin National Research Center of Oncology. Conclusion. The diagnosis and treatment of radiation-induced sarcomas remains a complex issue in modern oncology. The inclusion of these patients in clinical trials and even in the descriptions of individual clinical cases seems to be important steps towards finding an effective treatment for this pathology.

Full Text

Restricted Access

About the authors

Elena V. Lubennikova

N.N. Blokhin National Medical Research Center of Oncology

Email: lubennikova@yandex.ru

Michael E. Abramov

N.N. Blokhin National Medical Research Center of Oncology

Email: abramovm67@mail.ru

Sergei L. Gutorov

N.N. Blokhin National Medical Research Center of Oncology

Email: s1gutorov@gmail.com

Oxana P. Trofimova

N.N. Blokhin National Medical Research Center of Oncology

Email: dr.troflmova@mail.ru

Yana V. Vishnevskaya

N.N. Blokhin National Medical Research Center of Oncology

Email: yana_vishn@list.ru

Victoria A. Amosova

N.N. Blokhin National Medical Research Center of Oncology

Email: amosova_va@mail.ru

Galina V. Vyshinskaya

N.N. Blokhin National Medical Research Center of Oncology

Email: galina@userhost.ru

Elena I. Borisova

N.N. Blokhin National Medical Research Center of Oncology

Email: doctorborisova@ya.ru

Roman P. Litvinov

N.N. Blokhin National Medical Research Center of Oncology

Email: litvinov-roman@mail.ru

Ramis K. Valiev

N.N. Blokhin National Medical Research Center of Oncology

Email: radiosurgery@bk.ru

Mona A. Frolova

N.N. Blokhin National Medical Research Center of Oncology

Email: drfrolova@yandex.ru

Alexander V. Petrovsky

N.N. Blokhin National Medical Research Center of Oncology

Email: alexpetrovsky@hotmail.com

References

  1. Torres K.E., Ravi V., Kin K., et al. Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer. Ann Surg Oncol. 2013; 20(4): 1267-74. doi: 10.1245/s10434-012-2755-y.
  2. Stewart F.W., Treves N. Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica. Cancer 1948; 1(1): 64-81. doi: 10.1002/1097-0142(194805)1:1<64::aid-cncr2820010105>3.0.co;2-w
  3. Hamels J., Blondiau P., Mirgaux M. Cutaneous angiosarcoma arising in a mastectomy scar after therapeutic irradiation. Bull Cancer.1981; 68(4): 353-6. PMID: 6274455
  4. Davies J.D., Rees G.J., Mera S.L. Angiosarcoma in irradiated post-mastectomy chest wall. Histopathology. 1983; 7(6): 947-56. doi: 10.1111/j.1365-2559.1983. tb02309.x
  5. Veronesi U., Cascinelli N., Mariani L., Greco M., Saccozzi R., Luini A., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N. Engl J. Med. 2002; 347(16): 1227-32. doi: 10.1056/NEJMoa020989
  6. Yap J., Chuba P.J., Thomas R., Aref A., Lucas D., Severson R.K., et al. Sarcoma as a second malignancy after treatment for breast cancer. Int J. Radiat Oncol Biol Phys. 2002; 52(2): 1231-7. doi: 10.1016/S0360-3016(01)02799-7
  7. Wang X.Y., Jakowski J., Tawfik O.W., Thomas P.A., Fan F. Angiosarcoma of the breast: a clinicopathologic analysis of cases from the last 10 years. Ann Diagn Pathol, 2009; 13(3): 147-50. doi: 10.1016/j.anndiagpath.2009.02.001.
  8. Marchal C., Weber B., de Lafontan B., et al. Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers. Int J. Radiat Oncol Biol Phys. 1999; 44(1): 113-19. doi: https://doi.org/10.1016/S0360-3016(98)00537-9
  9. Lim S.Z., Ong K.W., Tan B.K., et al. Sarcoma of the breast: an update on a rare entity. J. Clin Pathol. 2016; 69(5): 373-81. doi: 10.1136/jclinpath-2015-203545.
  10. Chesebro A.L., Chikarmane S.A., Gombos E.C., Giardino A.A. Radiationassociated angiosarcoma of the breast: what the radiologist needs to know. AJR Am J. Roentgenol. 2016; 207(1): 217-25. doi: 10.2214/ AJR.15.15888
  11. Cahan W.G., Woodard H.Q., Higinbotham N.L., Stewart F.W., Coley B.L. Sarcoma arising in irradiated bone: report of eleven cases. 1948. Cancer.1998; 82(1): 8-34. doi: 10.1002/(sici)1097-0142(19980101)82:1<8::aid-cncr3>3.0.co;2-w
  12. Arlen M., Higinbotham N.L., Huvos A.G., Marcove R.C., Miller T., Shah I.C. Radiation-induced sarcoma of bone. Cancer. 1971; 28(5): 1087-99. doi: 10.1002/1097-0142(1971)28:5<1087::aid-cncr2820280502>3.0.co;2-f
  13. Morgan E.A., Kozono D.E., Wang Q., Mery C.M., Butrynski J.E., Baldini E.H., et al. Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Ann Surg Onc. 2012;19(12): 3801-8. doi: 10.1245/ s10434-012-2563-4.
  14. D’Angelo S.P., Antonescu C.R., Kuk D., Qin L., Moraco N., Carvajal R.C., et al. Highrisk features in radiation-associated breast angiosarcomas. Br J. Cancer. 2013; 109(9): 2340-6. doi: 10.1038/bjc.2013.590
  15. Abbott R., Palmieri C. Angiosarcoma of the breast following surgery and radiotherapy for breast cancer. Nat Clin Pract Oncol. 2008; 5(12): 727-36. doi: 10.1038/ncponc1242.
  16. Kelly NP, Siziopikou K. A 68-year-old woman with bluish discoloration of the skin of the breast. Arch Pathol Lab Med. 2002; 126(8): 989-90. doi: 10.1043/0003-9985(2002)126<0989:PQCAYO>2.0.CO;2
  17. Monroe A.T., Feigenberg S.J., Mendenhall N.P. Angiosarcoma after breastconserving therapy. Cancer. 2003; 97(8): 1832-40. doi: 10.1002/ cncr.11277
  18. Seinen J.M., Styring E., Verstappen V., Vult von Steyern F., Rydholm A., Suurmeijer A.J., et al. Radiation-associated angiosarcoma after breast cancer: high recurrence rate and poor survival despite surgical treatment with R0 resection. Ann Surg Oncol. 2012; 19(8): 2700-6. doi: 10.1245/s10434-012-2310-x.
  19. Depla A.L., Scharloo-Karels C.H., de Jong M.A., et al. Treatment and prognostic factors of radiation associated angiosarcoma (RAAS) after primary breast cancer: a systematic review. Eur J. Cancer. 2014; 50(10): 1779-88. doi: 10.1016/j. ejca.2014.03.002.
  20. Sinnamon A.J., Neuwirth M.G., McMillan M.T., Ecker B.L., Bartlett E.K., Zhang P.J., Kelz R.R., Fraker D.L., Roses R.E., Karakousis G.C. A prognostic model for resectable soft tissue and cutaneous angiosarcoma. J. Surg Oncol. 2016; 114(5): 557-63. doi: 10.1002/jso.24352.
  21. Fata F., O’Reilly E., Ilson D., et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999; 86: 2034-7. PMID: 10570428
  22. Casper E.S., Waltzman R.J., Schwartz G.K., Sugarman A., Pfister D., Ilson D., Woodruff J., Leung D., Bertino J.R. Phase II trial of paclitaxel in patients with soft-tissue sarcoma. Cancer Investig. 1998; 16(7): 442-6. doi: 10.3109/07357909809011697
  23. Itakura E., Yamamoto H., Oda Y., Tsuneyoshi M. Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas. J. Surg Oncol. 2008;97 (1): 74-81. doi: 10.1002/jso.20766
  24. Agulnik M., Yarber J.L., Okuno S.H., von Mehren M., Jovanovic B.D., Brockstein B.E., Evens A.M., Benjamin R.S. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol. 2013; 24(1): 257-63. doi: 10.1093/ annonc/mds237.
  25. Ray-Coquard I.L., Domont J., Tresch-Bruneel E., et al: Paclitaxel given once per week with or without bevacizumab in patients with advanced angiosarcoma: A randomized phase II trial. J. Clin Oncol. 2015; 33(25): 2797-802. doi: 10.1200/ JCO.2015.60.8505
  26. Сопромадзе С.В., Соболевский В.А., Крохина О.В., Феденко А.А. Лечение сарком молочной железы. Обзор литературы. Саркомы костей, мягких тканей и опухоли кожи. 2018;1: 33-38.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies